Americafirst Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-12,605
Closed -$1.84M 161
2016
Q4
$1.84M Buy
+12,605
New +$1.9M 1.94% 14
2014
Q4
Sell
-5,454
Closed -$766M 241
2014
Q3
$766M Buy
+5,454
New +$712K 0.38% 84

Other funds holding AMGN

Americafirst Capital Management's AMGN Position: Q1 2017 in Review

Americafirst Capital Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 12,605 shares — an estimated $1.84M sold.

Americafirst Capital Management first reported a position in AMGN in Q3 2014 and held it in 2 quarters. The position peaked at $766M in Q3 2014. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Americafirst Capital Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 12,605 Amgen shares in Q1 2017, an estimated $1.84M.
  • Americafirst Capital Management first reported a position in Amgen in Q3 2014 and held it in 2 quarters.
  • Americafirst Capital Management's Amgen position peaked at $766M in Q3 2014.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Americafirst Capital Management's 13F filing for Q1 2017, filed 17 Apr 2017.